PETERSON SCOTT ROBERT
Insider CIK 1563986 · ONTY Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 65,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 51,200 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 54,167 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 41,667 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 25,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 25,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 8,334 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 11,300 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 14,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 155,500 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 8,334 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 8,334 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | U Tender | 2018-03-09 | 2018-03-13 | 3,639 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2018-02-01 | 2018-02-02 | 155,500 | — | $0 | 155,500 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2018-01-11 | 2018-01-16 | 2,825 | — | $0 | 8,475 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2018-01-11 | 2018-01-16 | 923 | $3.92 | $3.6K | 3,639 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2018-01-11 | 2018-01-16 | 2,825 | — | $0 | 4,562 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-09-18 | 2017-09-20 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-09-18 | 2017-09-20 | 65,000 | — | $0 | 65,000 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-01-11 | 2017-01-13 | 11,300 | — | $0 | 11,300 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-01-11 | 2017-01-13 | 51,200 | — | $0 | 51,200 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2016-05-17 | 2016-05-19 | 325,000 | — | $0 | 325,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2015-09-24 | 2015-09-28 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2014-12-16 | 2014-12-16 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2013-12-12 | 2013-12-16 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2012-12-12 | 2012-12-14 | 50,000 | — | $0 | 50,000 | SEC↗ |